Checklist of disorders to monitor on calcitonin gene-related peptide inhibitor therapies
| System | Possible benefit | Possible caution/consider |
| Family history | SAH Osteoporosis | |
| Neurological | Multiple sclerosis Stroke | |
| Gastrointestinal | Constipation Peptic ulcer disease Inflammatory bowel disease | |
| Cardiovascular | Hypertension Pulmonary hypertension Vascular disease | |
| Endocrinological | Osteoporosis Pituitary dysfunction | |
| Skin | Psoriasis Atopic dermatitis | |
| Rheumatological | Osteoarthritis Rheumatoid arthritis |